29446 Federal Register / Vol. 79, No. 99 / Thursday, May 22, 2014 / Notices 

information will be reported for all sites 

in their grantee network. 

Need and Proposed Use of the 

Information: The Title X Family 

Planning Program (‘‘Title X program’’ or 

‘‘program’’) is the only Federal grant 

program dedicated solely to providing 

individuals with comprehensive family 

planning and related preventive health 

services (e.g., screening for breast and 

cervical cancer, sexually transmitted 

diseases (STDs), and human 

immunodeficiency virus [HIV]). By law, 

priority is given to persons from lowincome families (Section 1006[c] of Title 

X of the Public Health Service Act, 42 

USC 300). The Office of Population 

Affairs (OPA) within the Office of the 

Assistant Secretary for Health 

administers the Title X program. 

In fiscal year 2013, Congress 

appropriated approximately $296.8 

million for Title X family planning 

activities. In accordance with the statute 

and regulations (42 Code of Federal 

Regulations [CFR] part 59), at least 90% 

of the appropriation is used for clinical 

family planning services. In 2012, 98 

Title X grantees provided family 

planning services to five million women 

and men through a network of 4,400 

community-based clinics that include 

state and local health departments, 

tribal organizations, and other public 

and private nonprofit agencies. There is 

at least one clinic that receives Title X 

funds and provides services as required 

under the Title X statute in 73% of U.S. 

counties. 

Sixty percent of the clients seen at 

Title X funded service sites self-identify 

as being uninsured. Seventy percent of 

the total clients are under the age 30. 

Thus Title X service sites see a large 

proportion of young and uninsured 

individuals. Over the past years, OPA 

has encouraged grantees to develop 

enrollment programs to ensure that 

clients who are currently uninsured 

understand new health insurance 

options that are available as a result of 

the ACA. Some sites already assist 

individuals with enrolling in Medicaid 

and other public insurance programs. 

With the availability of the health 

insurance marketplace, many more 

service delivery sites are assisting 

clients enroll in health insurance 

programs. 

OPA does not have any data on how 

many sites are assisting and enrolling 

clients into health insurance programs. 

Thus we seek to collect this data in 

order to understand the impact of Title 

X funded service sites on assisting and 

enrolling clients into insurance 

programs. We will utilize this 

information to guide strategic planning 

around how Title X service sites and 

prepare for, and assist with, the full 

implementation of the ACA. Through a 

separate data collection process called 

the Family Planning Annual Report 

(FPAR) (OMB No. 0990–0221, 

expiration January 31, 2016), OPA 

collects information on the insurance 

status of the clients served. With the 

implementation of the ACA, many of 

the traditional clients served by Title X 

service sites will qualify for health 

insurance. 

Likely Respondents: This annual 

reporting requirement is for family 

planning services delivery projects 

authorized and funded by the Title X 

Family Planning Program. 

Burden Statement: Burden Statement: 

Burden in this context means the time 

expended by persons to generate, 

maintain, retain, disclose or provide the 

information requested. This includes 

the time needed to review instructions, 

to develop, acquire, install and utilize 

technology and systems for the purpose 

of collecting, validating and verifying 

information, processing and 

maintaining information, and disclosing 

and providing information, to train 

personnel and to be able to respond to 

a collection of information, to search 

data sources, to complete and review 

the collection of information, and to 

transmit or otherwise disclose the 

information. The total annual burden 

hours estimated for this ICR are 

summarized in the table below. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Total burden 

hours 

Outreach and Enrollment Activities ................ 4200 service sites .......................................... 1 0.20 840 

Darius Taylor, 

Information Collection Clearance Officer. 

[FR Doc. 2014–11836 Filed 5–21–14; 8:45 am] 

BILLING CODE 4150–34–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[Docket No. ATSDR–2014–0002] 

Proposed Substances to be Evaluated 

for Set 28 Toxicological Profiles 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Request for comments on the 

proposed substances to be evaluated for 

Set 28 toxicological profiles. 

SUMMARY: ATSDR is initiating the 

development of its 28th set of 

toxicological profiles (CERCLA Set 28). 

This notice announces the list of 

proposed substances that will be 

evaluated for CERCLA Set 28 

toxicological profile development. 

ATSDR’s Division of Toxicology and 

Human Health Sciences is soliciting 

public nominations from the list of 

proposed substances to be evaluated for 

toxicological profile development. 

ATSDR also will consider the 

nomination of any additional, nonCERCLA substances that may have 

public health implications, on the basis 

of ATSDR’s authority to prepare 

toxicological profiles for substances not 

found at sites on the National Priorities 

List. The agency will do so in order to 

‘‘. . . establish and maintain inventory 

of literature, research, and studies on 

the health effects of toxic substances’’ 

under CERCLA Section 104(i)(1)(B), to 

respond to requests for consultation 

under section 104(i)(4), and to support 

the site-specific response actions 

conducted by ATSDR, as otherwise 

necessary. 

DATES: Nominations from the Substance 

Priority List and/or additional 

substances must be submitted no later 

than June 20, 2014. 

ADDRESSES: You may submit 

nominations, identified by Docket No. 

ATSDR–2014–0002, by any of the 

following methods: 

*Internet: Access the Federal 

eRulemaking portal at http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 99 / Thursday, May 22, 2014 / Notices 29447 

*Mail: Division of Toxicology and 

Human Health Sciences, 1600 Clifton 

Rd. NE., MS F–57, Atlanta, Ga. 30333 

Instructions: All submissions must 

include the agency name and docket 

number for this notice. All relevant 

comments will be posted without 

change. This means that no confidential 

business information or other 

confidential information should be 

submitted in response to this notice. 

Refer to the section Submission of 

Nominations (below) for the specific 

information required. 

FOR FURTHER INFORMATION CONTACT: For 

further information, please contact 

Commander Jessilynn B. Taylor, 

Division of Toxicology and Human 

Health Sciences, 1600 Clifton Rd. NE., 

MS F–57, Atlanta, Ga. 30333, Email: 

tpcandidatecomments@cdc.gov; phone: 

1–800–232–4636. 

SUPPLEMENTARY INFORMATION: The 

Comprehensive Environmental 

Response, Compensation, and Liability 

Act of 1980, as amended (CERCLA or 

Superfund) [42 U.S.C. 9601 et seq.] 

establishes certain requirements for 

ATSDR and the U.S. Environmental 

Protection Agency (EPA) with regard to 

hazardous substances most commonly 

found at facilities on the CERCLA 

National Priorities List (NPL). Among 

these statutory requirements is a 

mandate for the Administrator of 

ATSDR to prepare toxicological profiles 

for each substance included on the 

Priority List of Hazardous Substances. 

This list identifies 275 hazardous 

substances that ATSDR and EPA have 

determined pose the most significant 

current potential threat to human 

health. The revised list of the 275 

priority substances is available at 

www.atsdr.cdc.gov/SPL. For prior 

versions of the list of substances, see 

www.atsdr.cdc.gov/SPL/resources. 

Substances to be Evaluated for Set 28 

Toxicological Profiles 

Each year, ATSDR develops a list of 

substances to be considered for 

toxicological profile development. The 

Set 28 nomination process includes 

consideration of all substances on 

ATSDR’s Priority List of Hazardous 

Substances, also known as the 

Substance Priority List (SPL), as well as 

other substances nominated by the 

public. The 275 substances on the SPL 

will be considered for Set 28 

Toxicological Profile development. This 

list may be found at the following Web 

site: www.atsdr.cdc.gov/SPL and in the 

docket at www.regulations.gov. Existing 

Toxicological Profiles may be found at 

the following Web site: http:// 

www.atsdr.cdc.gov/toxprofiles/ 

index.asp. 

Submission of Nominations for the 

Evaluation of Set 28 Proposed 

Substances: Today’s notice invites 

voluntary public nominations for 

substances included on the SPL and for 

substances not listed on the SPL. All 

nominations should include the full 

name of the nominator, affiliation, email 

address. When nominating a non-SPL 

substance, please include the rationale 

for the nomination. Please note that 

email addresses will not be posted on 

regulations.gov. 

ATSDR will evaluate all data and 

information associated with nominated 

substances and will determine the final 

list of substances to be chosen for 

toxicological profile development. 

Substances will be chosen according to 

ATSDR’s specific guidelines for 

selection. These guidelines can be found 

in the Selection Criteria announced in 

the Federal Register on May 7, 1993 

(58FR27286–27287). A hard copy of the 

selection criteria is available upon 

request or may be accessed at the 

following Web site: http://www.atsdr.

cdc.gov/toxprofiles/guidance/criteria_

for_selecting_tp_support.pdf. 

Please ensure that your comments are 

submitted within the specified 

nomination period. Nominations 

received after the closing date will be 

marked as late and may be considered 

only if time and resources permit. 

Sascha Chaney, 

Acting Director, Office of Policy, Planning 

and Evaluation, National Center for 

Environmental Health/Agency for Toxic, 

Substances and Disease Registry. 

[FR Doc. 2014–11848 Filed 5–21–14; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated Review Group 

Clinical Research and Field Studies of 

Infectious Diseases Study Section. 

Date: June 16, 2014. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Kabuki, 1625 Post Street, San 

Francisco, CA 94115. 

Contact Person: Soheyla Saadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3211, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0903, saadisoh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Primate 

Skeletal Database. 

Date: June 19, 2014. 

Time: 12:00 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Daniel F. McDonald, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4110, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1215, mcdonald@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 16, 2014. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–11807 Filed 5–21–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

mstockstill on DSK4VPTVN1PROD with NOTICES